Brief: Epigenomics Says U.S. Centers For Medicare & Medicaid Services Issued Negative Reimbursement Decision For Epi Procolon
19/01/2021 23:07
Jan 19 (Reuters) - Epigenomics AG ECXn.DE :
* EPIGENOMICS- U.S. CENTERS FOR MEDICARE & MEDICAID SERVICES
ISSUED NEGATIVE REIMBURSEMENT DECISION FOR EPI PROCOLON
* EPIGENOMICS AG - U.S. CENTERS FOR MEDICARE & MEDICAID
SERVICES'
DECISION IS IN CONNECTION WITH NATIONAL COVERAGE DETERMINATION
OF EPI PROCOLON
* EPIGENOMICS AG ECXn.DE - CO IS CURRENTLY EVALUATING
OPTIONS
FOR AN APPEAL, LITIGATION AND/OR OTHER ALTERNATIVES TO ACHIEVE
MEDICARE COVERAGE
Source text for Eikon: ID:nEQb6KvfTa
Further company coverage: ECXn.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns